SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-045115
Filing Date
2017-07-13
Accepted
2017-07-13 19:39:03
Documents
1
Period of Report
2017-07-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3988
  Complete submission text file 0001209191-17-045115.txt   5523
Mailing Address INSPIRE PHARMACEUTICALS, INC., 4222 EMPEROR BLVD., STE. 470 DURHAM NC 27703-8466
Business Address
SHAFFER CHRISTY L (Reporting) CIK: 0001145929 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38096 | Film No.: 17964323

Mailing Address P. O. BOX # 110341 RESEARCH TRIANGLE PARK NC 27709
Business Address 79 T.W. ALEXANDER DRIVE 4501 RESEARCH COMMONS, SUITE 100 RESEARCH TRIANGLE PARK NC 27709 919-213-9835
G1 Therapeutics, Inc. (Issuer) CIK: 0001560241 (see all company filings)

IRS No.: 263648180 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations